Literature DB >> 15790984

Oxidative stress and airway inflammation in severe exacerbations of COPD.

E M Drost1, K M Skwarski, J Sauleda, N Soler, J Roca, A Agusti, W MacNee.   

Abstract

BACKGROUND: A study was undertaken to assess both oxidative stress and inflammation in the lungs of patients with chronic obstructive pulmonary disease (COPD) during severe and very severe exacerbations compared with those with stable COPD, healthy smokers, and non-smokers. Two sites within the lungs were compared: the large airways (in sputum) and the peripheral airways (by bronchoalveolar lavage (BAL)).
METHODS: BAL fluid cell numbers and levels of tumour necrosis factor (TNFalpha) and interleukin (IL)-8 were measured as markers of airway inflammation and glutathione (GSH) levels as a marker of antioxidant status. Nuclear translocation of the pro-inflammatory transcription factors nuclear factor-kappaB (NF-kappaB) and activator protein 1 (AP-1) were also measured by electromobility shift assay in BAL fluid leucocytes and lung biopsy samples.
RESULTS: Influx of inflammatory cells into the peripheral airways during exacerbations of COPD was confirmed. Increased IL-8 levels were detected in BAL fluid from patients with stable COPD compared with non-smokers and healthy smokers, with no further increase during exacerbations. In contrast, IL-8 levels in the large airways increased during exacerbations. GSH levels were increased in the BAL fluid of smokers (444%) and patients with stable COPD (235%) compared with non-smokers and were reduced during exacerbations (severe 89.2%; very severe 52.3% compared with stable COPD). NF-kappaB DNA binding in BAL leucocytes was decreased in healthy smokers compared with non-smokers (41.3%, n = 9, p<0.001) but did not differ in COPD patients, whereas AP-1 DNA binding was significantly decreased during exacerbations of COPD.
CONCLUSION: There is evidence of increased oxidative stress in the airways of patients with COPD that is increased further in severe and very severe exacerbations of the disease. This is associated with increased neutrophil influx and IL-8 levels during exacerbations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15790984      PMCID: PMC1747355          DOI: 10.1136/thx.2004.027946

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  46 in total

1.  Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease.

Authors:  P Paredi; S A Kharitonov; D Leak; S Ward; D Cramer; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  2000-08       Impact factor: 21.405

2.  Inhaled corticosteroids may reduce neutrophilic inflammation in patients with stable chronic obstructive pulmonary disease.

Authors:  F Yildiz; A C Kaur; A Ilgazli; M Celikoglu; S Kaçar Ozkara; N Paksoy; O Ozkarakaş
Journal:  Respiration       Date:  2000       Impact factor: 3.580

3.  Systemic oxidative stress in asthma, COPD, and smokers.

Authors:  I Rahman; D Morrison; K Donaldson; W MacNee
Journal:  Am J Respir Crit Care Med       Date:  1996-10       Impact factor: 21.405

4.  Cytokine-induced activation of nuclear factor-kappa B is inhibited by hydrogen peroxide through oxidative inactivation of IkappaB kinase.

Authors:  S H Korn; E F Wouters; N Vos; Y M Janssen-Heininger
Journal:  J Biol Chem       Date:  2001-07-30       Impact factor: 5.157

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

6.  Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers.

Authors:  P Montuschi; J V Collins; G Ciabattoni; N Lazzeri; M Corradi; S A Kharitonov; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

7.  Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.

Authors:  S D Aaron; J B Angel; M Lunau; K Wright; C Fex; N Le Saux; R E Dales
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

8.  Tobacco-smoke-inducible human haem oxygenase-1 gene expression: role of distinct transcription factors and reactive oxygen intermediates.

Authors:  F Favatier; B S Polla
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

9.  Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema.

Authors:  M Tanino; T Betsuyaku; K Takeyabu; Y Tanino; E Yamaguchi; K Miyamoto; M Nishimura
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

10.  Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis.

Authors:  I S Woolhouse; D L Bayley; R A Stockley
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

View more
  120 in total

Review 1.  Neutrophils cascading their way to inflammation.

Authors:  Christian D Sadik; Nancy D Kim; Andrew D Luster
Journal:  Trends Immunol       Date:  2011-08-11       Impact factor: 16.687

2.  Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung.

Authors:  E L Hardaker; M S Freeman; N Dale; P Bahra; F Raza; K H Banner; C Poll
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients.

Authors:  Deepti Malhotra; Rajesh K Thimmulappa; Nicolas Mercado; Kazuhiro Ito; Ponvijay Kombairaju; Sarvesh Kumar; Jinfang Ma; David Feller-Kopman; Robert Wise; Peter Barnes; Shyam Biswal
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

Review 4.  Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease.

Authors:  Caroline A Owen
Journal:  Proc Am Thorac Soc       Date:  2005

Review 5.  COPD exacerbations.5: management.

Authors:  R Rodríguez-Roisin
Journal:  Thorax       Date:  2006-06       Impact factor: 9.139

6.  Glutathione peroxidase 2, the major cigarette smoke-inducible isoform of GPX in lungs, is regulated by Nrf2.

Authors:  Anju Singh; Tirumalai Rangasamy; Rajesh K Thimmulappa; Hannah Lee; William O Osburn; Regina Brigelius-Flohé; Thomas W Kensler; Masayuki Yamamoto; Shyam Biswal
Journal:  Am J Respir Cell Mol Biol       Date:  2006-06-22       Impact factor: 6.914

7.  Effects of cigarette smoke on Toll-like receptor (TLR) activation of chronic obstructive pulmonary disease (COPD) macrophages.

Authors:  H J Metcalfe; S Lea; D Hughes; R Khalaf; K Abbott-Banner; D Singh
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

8.  Comparative cytoprotective effects of carbocysteine and fluticasone propionate in cigarette smoke extract-stimulated bronchial epithelial cells.

Authors:  Elisabetta Pace; Maria Ferraro; Serena Di Vincenzo; Chiara Cipollina; Stefania Gerbino; Diego Cigna; Valentina Caputo; Rossella Balsamo; Luigi Lanata; Mark Gjomarkaj
Journal:  Cell Stress Chaperones       Date:  2013-04-12       Impact factor: 3.667

9.  Abnormal levels of circulating endothelial progenitor cells during exacerbations of COPD.

Authors:  Ernest Sala; Cristina Villena; Catalina Balaguer; Angel Ríos; Carlos Fernández-Palomeque; Borja G Cosío; Javier García; Aina Noguera; Alvar Agustí
Journal:  Lung       Date:  2010-01-14       Impact factor: 2.584

10.  Influence of a moderate physical activity intervention on red cell deformability in patients suffering from chronic obstructive pulmonary disease (COPD).

Authors:  Basit Ahmad; Nina Ferrari; Georgina Montiel; Wilhelm Bloch; Anke Raabe-Oetker; Nina Skrobala; Klara Brixius
Journal:  Wien Med Wochenschr       Date:  2013-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.